Previous Article | Next Article ![]()
Journal of Clinical Microbiology, May 1999, p. 1554-1560, Vol. 37, No. 5
Instituto de Medicina Tropical de São
Paulo,
Received 26 October 1998/Returned for modification 5 January
1999/Accepted 2 February 1999
The commercially available diagnostic tests for Chagas' disease
employ whole extracts or semipurified fractions of
Trypanosoma cruzi epimastigotes. Considerable variation in
the reproducibility and reliability of these tests has been reported by
different research laboratories, mainly due to cross-reactivity with
other pathogens and standardization of the reagents. The use of
recombinant antigens for the serodiagnosis of Chagas' disease is
recommended to increase the sensitivity and specificity of serological
tests. Expressed in Escherichia coli, as fusion products
with glutathione S-transferase, six T. cruzi
recombinant antigens (H49, JL7, A13, B13, JL8, and 1F8) were evaluated
in an enzyme-linked immunosorbent assay for Chagas' disease. The study
was carried out with a panel of 541 serum samples of chagasic and
nonchagasic patients from nine countries of Latin America (Argentina,
Bolivia, Brazil, Chile, Colombia, El Salvador, Guatemala, Honduras, and
Venezuela). The optimal concentration of each recombinant antigen for
coating of plates was determined with the help of
125I-labelled recombinant proteins. While the specificity
of the epimastigote antigen was 84% because of false positives from
leishmaniasis cases, for the recombinant antigens it varied from 96.2 to 99.6%. Recombinant antigens reacted with 79 to 100% of serum
samples from chronic chagasic patients. In this way, it is proposed
that a mixture of a few T. cruzi recombinant antigens
should be employed in a diagnostic kit to minimize individual variation
and promote high sensitivity in the diagnosis of Chagas' disease.
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Evaluation of Recombinant Antigens for
Serodiagnosis of Chagas' Disease in South and Central
America
*
Corresponding author. Mailing address: Instituto de
Medicina Tropical de São Paulo, FMUSP, Av. Dr. Enéas de
Carvalho Aguiar 470, CEP 05403-000, São Paulo, Brazil. Phone: 55 11 30 66 70 15. Fax: 55 11 852 36 22. E-mail:
eumezawa{at}usp.br.
Journal of Clinical Microbiology, May 1999, p. 1554-1560, Vol. 37, No. 5
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|